| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/2005 | US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells |
| 04/28/2005 | US20050089535 Delivery of biologically active agents |
| 04/28/2005 | US20050089530 Selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | US20050089522 Treating a bone cancer patient with a monoclonal antibody that specifically binds a RANK (receptor activator of NF- kappa B) polypeptide with specific amino acid sequence for inhibiting RANK-induced osteoclastogenesis |
| 04/28/2005 | US20050089518 Prospective identification and characterization of breast cancer stem cells |
| 04/28/2005 | US20050089516 Artificial skin; mixture of protein and serine protease inhibitor |
| 04/28/2005 | US20050089515 Poly-pegylated protease inhibitors |
| 04/28/2005 | US20050089514 Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections |
| 04/28/2005 | US20050089511 Methods and compositions comprising DNA damaging agents and p53 |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | US20050089509 Treatment of Francisella infection with an IFN-gamma inducer and a chemotherapeutic agent |
| 04/28/2005 | US20050089508 Method of using GM-CSF to modulate food intake and regulate body weight |
| 04/28/2005 | US20050089507 G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| 04/28/2005 | US20050089480 Active polypeptides for nasal sprays with polysaccharides like dextran |
| 04/28/2005 | CA2576040A1 Hydrogel-containing medical articles and methods of using and making the same |
| 04/28/2005 | CA2546623A1 Cystatin c as an antagonist of tgf-.beta. and methods related thereto |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542765A1 Method of inhibiting secretase activity |
| 04/28/2005 | CA2542684A1 Targeting compositions and preparation thereof |
| 04/28/2005 | CA2542662A1 Pharmaceutical combinations comprising il-21 |
| 04/28/2005 | CA2542639A1 Novel heat shock protein 20-related polypeptides and uses therefor |
| 04/28/2005 | CA2542618A1 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | CA2542433A1 Use of growth hormone releasing factor analogs in treating patients suffering from wasting |
| 04/28/2005 | CA2542332A1 Immunomodulating compositions and uses therefor |
| 04/28/2005 | CA2542269A1 Fusion molecules comprising antigens and mhc i or ii cytoplasmic domains |
| 04/28/2005 | CA2542155A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 04/28/2005 | CA2542074A1 Methods and reagents for the treatment of immunoinflammatory disorders |
| 04/28/2005 | CA2541857A1 Combination therapy for hcv infection |
| 04/28/2005 | CA2541764A1 Method for producing gamma-carboxylated proteins |
| 04/28/2005 | CA2541634A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/28/2005 | CA2540324A1 Stabilization of pharmaceutical protein formulations with small peptides |
| 04/28/2005 | CA2536082A1 Therapeutic uses of chemokine variants |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1526177A1 Nucleic acids useful for triggering tumor cell lethality |
| 04/27/2005 | EP1526175A2 Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics |
| 04/27/2005 | EP1526172A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1525889A1 Liquid pharmaceutical composition containing an erythropoietin derivative |
| 04/27/2005 | EP1525888A1 Angiogenically effective unit dose of FGF-2 and method of use |
| 04/27/2005 | EP1525798A2 Carbohydrate oxidase and use thereof in baking |
| 04/27/2005 | EP1525549A2 Method for bioequivalence determination using expression profiling |
| 04/27/2005 | EP1525478A2 SHIGA TOXIN B-SUBUNIT AS A VECTOR FOR TUMOR DIAGNOSIS AND DRUG DELIVERY TO GB sb 3 /sb EXPRESSING TUMORS |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525311A2 Protein complexes of the tip60 transcriptional activator protein as well as components, fragments and derivatives thereof and methods for using the same |
| 04/27/2005 | EP1525310A2 Cancer therapy by modulating cdc42-activity |
| 04/27/2005 | EP1525221A1 Conjugate of notch signalling pathway modulators and their use in medical treatment |
| 04/27/2005 | EP1525219A1 Glp-1 and methods for treating diabetes |
| 04/27/2005 | EP1525218A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |
| 04/27/2005 | EP1525216A2 Combination therapy for treatment of hiv infection |
| 04/27/2005 | EP1525209A2 1'-, 2'- and 3' -modified nucleoside derivatives for treating flaviviridae infections |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1524998A1 Stable pharmaceutical composition comprising erythropoietin |
| 04/27/2005 | EP1524995A1 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 04/27/2005 | EP1524989A2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 04/27/2005 | EP1524988A1 Use of a proteasome inhibitor in the treatment of fibrotic diseases |
| 04/27/2005 | EP1524977A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/27/2005 | EP1524912A1 Compositions comprising lactoferrin |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1263778B1 Peptide inhibitors of lfa-1/icam-1 interaction |
| 04/27/2005 | EP1253932B1 Botulinum toxin pharmaceutical compositions |
| 04/27/2005 | EP1225814B1 Fibrous-liponutritional complexes and compositions containing them |
| 04/27/2005 | EP1220620B1 Composition comprising casein protein and whey protein |
| 04/27/2005 | EP1217993B1 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 04/27/2005 | EP1143974B1 Pharmaceutical compositions for alleviating discomfort |
| 04/27/2005 | EP1135153B1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 04/27/2005 | EP1039931B1 Multivalent recombinant antibodies for treating hrv infections |
| 04/27/2005 | EP1033997B1 Method of mobilizing hematopoietic stem cells |
| 04/27/2005 | EP1018003B1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof |
| 04/27/2005 | EP1015019B1 Compositions and methods of therapy for igf-i-responsive conditions |
| 04/27/2005 | EP0939818B1 Recombinant toxin fragments |
| 04/27/2005 | EP0935470B1 Method for treating allergic lung disease |
| 04/27/2005 | EP0910572B1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation |
| 04/27/2005 | EP0880359B1 Nima interacting proteins |
| 04/27/2005 | EP0833651B1 Analgesic use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/27/2005 | EP0670896B2 Cloning and expression of biologically active alpha-galactosidase a |
| 04/27/2005 | CN1610743A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/27/2005 | CN1610697A E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 04/27/2005 | CN1610694A Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders |
| 04/27/2005 | CN1610693A Transdifferentiation of pancreatic acinar cells |
| 04/27/2005 | CN1610692A Process for preparing glycopeptide derivatives |
| 04/27/2005 | CN1610567A Enhanced systemic absorption of intradermally delivered substances |
| 04/27/2005 | CN1610564A Compositions and methods of using collajolie |
| 04/27/2005 | CN1610563A Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 04/27/2005 | CN1610556A Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 04/27/2005 | CN1610555A Eye drops |
| 04/27/2005 | CN1610551A Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1610538A Microemulsion preconcentrate |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1609616A Specific markers for diabetes |
| 04/27/2005 | CN1609124A Calreticulin-tumor necrosis factor correlated apoptosis inducing ligand fusion protein and its prepn and use |
| 04/27/2005 | CN1609121A Antibiotic peptides and their prepn process and application |
| 04/27/2005 | CN1609119A Peptide library, its synthesis process and active segment screened from the peptide library |
| 04/27/2005 | CN1609118A Cell wall acyl-alanyl-D-isoglutamine derivative and its prepn, medicine composition and use |
| 04/27/2005 | CN1608673A Prepn process of S190 polypeptide vaccine and its application in resisting SARS virus |
| 04/27/2005 | CN1608672A Thrombocyte increasing medicine prepn and its prepn process |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198936C Alzheimer's disease secretase |